Two immunotherapies merged into single, more effective treatment
Researchers at Washington University School of Medicine have combined two types of immunotherapy into a single treatment that may be more effective and possibly safer than current immunotherapies for blood cancers.
New targets for childhood brain tumors identified
People with the genetic condition neurofibromatosis type 1 are prone to developing tumors on nervous system tissue. A new study from Washington University School of Medicine has found that the development and growth of such tumors are driven by nearby noncancerous neurons and immune cells.
Cancerous tumors, surrounding cells illuminated by new imaging agent
Scientists at Washington University School of Medicine have developed a new imaging agent that could let doctors identify tumors as well as the surrounding normal cells that act as a shield, protecting the tumor from various treatment strategies.
Radiation therapy for colon cancer works better when specific protein blocked
Members of the School of Medicine lab of Matthew Ciorba, MD, have identified a way to make radiation therapy for colorectal cancer more effective by inhibiting a protein found in cancer cells in the gut.
Cancer survival disparities in minority children, adolescents greater for more treatable cancers
Racial and ethnic minority children and adolescents with cancer have a higher risk of death than non-Hispanic white children and adolescents, with evidence for larger disparities in survival for more treatable cancers, finds a new study from the Brown School at Washington University in St. Louis.
Fight against endometrial cancer boosted with new molecular road map
A new study offers a road map to understanding the molecular underpinnings of endometrial cancer, which could lead to new therapies. The national research team was co-led by investigators at the School of Medicine.
Mutations in donors’ stem cells may cause problems for cancer patients
A new study from the School of Medicine suggests that bone marrow — or blood stem cells — from healthy donors can harbor extremely rare mutations that can cause health problems for the cancer patients who receive them. Such stem cell transplants are important for treating blood cancers, including acute myeloid leukemia.
Investigational drugs block bone loss in mice receiving chemotherapy
Exposure to chemotherapy and radiation during cancer treatment leads to bone loss and increases the risk of osteoporosis and fractures. A new School of Medicine study identifies the trigger for this bone loss and suggests ways to prevent it.
In transfusions for children, fresh and older blood are equally effective
An international study led by the School of Medicine and CHU Sainte-Justine hospital in Montreal has found no benefit in using fresh red blood cells that have been stored for up to seven days in blood transfusions for critically ill children, compared with using older red blood cells stored for nearly four weeks.
Machine learning, imaging technique may boost colon cancer diagnosis
Researchers at the McKelvey School of Engineering have devised a new imaging technique based on a technology that has been used for two decades in ophthalmology that can provide accurate, real-time, computer-aided diagnosis of colorectal cancer.
Older Stories